You are here

XORTX Therapeutics Inc.

Listing Exchange: 
CSE
Status: 
Active
Industry: 
Life Sciences
Symbol: 
XRX
CSE Index: 
Currency: 

XORTX Therapeutics Inc. is a BioPharmaceutical company focused on developing innovative therapies to treat progressive kidney disease.  XORTX has lead programs to develop treatments for progressive kidney disease due to diabetes, diabetic nephropathy and polycystic kidney disease.  Secondary programs focus on developing therapies for health consequences that accompany pre-diabetes, diabetes and cardiovascular disease. Additional information on XORTX Therapeutics is available at www.XORTX.com.

You are here

XORTX Therapeutics Inc. (XRX)

SEDAR Information

Company Info

Address
Suite 2400 - 745 Thurlow Street
Vancouver, BC V6E 0C5
Canada
Phone
(403) 607-2621
Email
adavidoff@xortx.com
Listing date
Wednesday, September 30, 2015
Transfer Agent
TSX Trust Company
Auditor
Morgan & Company LLP

Advertisement

Publicité

Capitalization

Issued & Outstanding: 
62,919,691
Reserved for Issuance: 
4,004,740

Company Officers

Allen Davidoff, President and Chief Executive Officer
David Matthews, Chief Financial Officer
Charlotte May, Corporate Secretary
W. Bruce Rowlands, Director
Paul J. Van Damme, Director
Alan W. Williams, Director

Bulletins

10/01/2018

2018-0111 – Fundamental Change – APAC Resources Inc./XORTX Therapeutics Inc.

Le 10 janvier/January 2018

XORTX Therapeutics Inc., the issuer resulting from a Fundamental Change of APAC Resources Inc. has been approved for listing.

Advertisement

Publicité

Latest CSE News

Upcoming Events

04_20_CSE_Talks_Montreal_Website

CSE Talks Montreal: Four Months Into Legalization ... What Now?

Wednesday, February 20, 2019 -
4:00pm to 7:00pm
02_21_CSE_Talks_Ottawa_Website_v3

CSE Talks Ottawa: Four Months Into Legalization ... What Now?

Thursday, February 21, 2019 -
12:00pm to 3:00pm
02_26_PreDac_Toronto_2019_Website

PreDAC Toronto 2019

Tuesday, February 26, 2019 -
3:00pm to 5:30pm